Literature DB >> 24794490

Tailored approach to early psoriatic arthritis patients: clinical and ultrasonographic predictors for structural joint damage.

Yasser El Miedany1, Maha El Gaafary, Sally Youssef, Ihab Ahmed, Annie Nasr.   

Abstract

This study aims to identify the clinical predictors of arthritis in patients with psoriasis and to evaluate the use of musculoskeletal ultrasonography (US) as a predictor for inflammatory structural progression in psoriatic patients. Measures of association (odds ratio (OR)) were tested, in a prospective, cohort 1-year follow-up study, between structural deterioration and the presence of baseline inflammation, or its persistence. One hundred twenty-six psoriatic patients were prospectively evaluated both clinically and by US at 0, 6, and 12 months for synovitis/ joint damage, enthesitis, and onychopathy. X-ray was performed at 0 and 12 months. One hundred twelve sex and age-matched pasoriatic patients without histories of musculoskeletal symptoms were included as control group. Structural deterioration was observed in 47% of the 5,292 evaluated joints. Clinical variables associated with arthritis risk: BMI > 25 (OR = 1.7), body surface area (OR = 1.13), family history (OR = 5.72) and nail involvement (OR = 2.25). BMI > 30 was significantly correlated (P < 0.01) with shorter time for the onset of arthritis. Baseline synovial score/PD score ≥ 2 was associated with increased risk of structural progression: OR = 1.98 versus 2.61 versus 2.66 (P < 0.001) for the clinical versus US-gray scale (GS) versus US-power Doppler (PD) evaluation, respectively. An increased probability for structural progression in the presence of enthesitis was observed (OR = 2.79 and 3.50) for both US-GS and US-PD, whereas OR was 2.46 for clinical examination. Onychopathy was associated with structural joint damage (OR = 2.30). In multivariate logistic regression analysis, persistent of synovitis/enthesitis at 6 months of therapy was predictive of subsequent structural progression. Family history of psoriatic arthritis, large BMI (>25), high percentage of psoriatic body surface area, and nail involvement were significantly associated with early onset psoriatic arthritis. Baseline GS score of ≥2, PD score of ≥2, presence of enthesitis, enhanced vascularity at enthesitis, higher GUESS score, and onychopathy, all at base line as well as persistent synovitis and enthesitis at 6 months are predictors of progressive early psoriatic arthritis. Regular ultrasonographic monitoring of these patients is mandatory to assess the progression of their arthritis status.

Entities:  

Mesh:

Year:  2014        PMID: 24794490     DOI: 10.1007/s10067-014-2630-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  44 in total

1.  Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy.

Authors:  P V Balint; D Kane; H Wilson; I B McInnes; R D Sturrock
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

2.  Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

Authors:  D D Gladman; V T Farewell; K Wong; J Husted
Journal:  Arthritis Rheum       Date:  1998-06

3.  Recommendations of the Italian Society for Rheumatology for the use of biologic (TNF-alpha blocking) agents in the treatment of psoriatic arthritis.

Authors:  C Salvarani; I Olivieri; N Pipitone; F Cantini; A Marchesoni; L Punzi; R Scarpa; M Matucci-Cerinic
Journal:  Clin Exp Rheumatol       Date:  2006 Jan-Feb       Impact factor: 4.473

4.  Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.

Authors:  L Williamson; N Dalbeth; J L Dockerty; B C Gee; R Weatherall; B P Wordsworth
Journal:  Rheumatology (Oxford)       Date:  2004-04-27       Impact factor: 7.580

5.  Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease.

Authors:  S M Jones; J B Armas; M G Cohen; C R Lovell; G Evison; N J McHugh
Journal:  Br J Rheumatol       Date:  1994-09

6.  Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.

Authors:  C Fernández-Espartero; E de Miguel; E Loza; E Tomero; M Gobbo; M A Descalzo; E Collantes-Estévez; J Mulero; S Muñoz-Fernández; P Zarco; L Carmona
Journal:  Ann Rheum Dis       Date:  2013-05-24       Impact factor: 19.103

7.  Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis.

Authors:  Salvatore D'Angelo; Gianna Angela Mennillo; Maria Stefania Cutro; Pietro Leccese; Angelo Nigro; Angela Padula; Ignazio Olivieri
Journal:  J Rheumatol       Date:  2009-02-04       Impact factor: 4.666

8.  A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience.

Authors:  D Kane; L Stafford; B Bresnihan; O FitzGerald
Journal:  Rheumatology (Oxford)       Date:  2003-10-01       Impact factor: 7.580

9.  Usefulness of ultrasound imaging in detecting psoriatic arthritis of fingers and toes in patients with psoriasis.

Authors:  Clara De Simone; Giacomo Caldarola; Magda D'Agostino; Angelo Carbone; Cristina Guerriero; Lorenzo Bonomo; Pierluigi Amerio; Nicola Magarelli
Journal:  Clin Dev Immunol       Date:  2011-02-08

10.  Ultrasonography, magnetic resonance imaging, radiography, and clinical assessment of inflammatory and destructive changes in fingers and toes of patients with psoriatic arthritis.

Authors:  Charlotte Wiell; Marcin Szkudlarek; Maria Hasselquist; Jakob M Møller; Aage Vestergaard; Jesper Nørregaard; Lene Terslev; Mikkel Østergaard
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  13 in total

Review 1.  Ultrasound in psoriatic arthritis. Can it facilitate a best routine practice in the diagnosis and management of psoriatic arthritis?

Authors:  Marwin Gutierrez; Antonella Draghessi; Chiara Bertolazzi; Gian Luca Erre; Lina Maria Saldarriaga-Rivera; Alberto López-Reyes; Javier Fernández-Torres; Marcelo J Audisio; Carlos Pineda
Journal:  Clin Rheumatol       Date:  2015-08-23       Impact factor: 2.980

Review 2.  Entheseal involvement in systemic disorders.

Authors:  Gleb Slobodin; Doron Rimar; Nina Boulman; Lisa Kaly; Michael Rozenbaum; Itzhak Rosner; Majed Odeh
Journal:  Clin Rheumatol       Date:  2015-09-10       Impact factor: 2.980

3.  Subclinical enthesopathy in patients with psoriasis and its association with other disease parameters: a power Doppler ultrasonographic study.

Authors:  Abdelhafeez Moshrif; Ahmed Mosallam; Essam Elden M Mohamed; Wesam Gouda; Mostafa Doma
Journal:  Eur J Rheumatol       Date:  2017-03-01

4.  Diagnosis, prognosis and classification of early arthritis: results of a systematic review informing the 2016 update of the EULAR recommendations for the management of early arthritis.

Authors:  Charlotte Hua; Claire I Daien; Bernard Combe; Robert Landewe
Journal:  RMD Open       Date:  2017-01-05

5.  The association between sonographic enthesitis and radiographic damage in psoriatic arthritis.

Authors:  Ari Polachek; Richard Cook; Vinod Chandran; Dafna D Gladman; Lihi Eder
Journal:  Arthritis Res Ther       Date:  2017-08-15       Impact factor: 5.156

6.  Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort study.

Authors:  José Inciarte-Mundo; Julio Ramirez; Maria Victoria Hernández; Virginia Ruiz-Esquide; Andrea Cuervo; Sonia Raquel Cabrera-Villalba; Mariona Pascal; Jordi Yagüe; Juan D Cañete; Raimon Sanmarti
Journal:  Arthritis Res Ther       Date:  2018-12-13       Impact factor: 5.156

Review 7.  Novel Concepts in Psoriatic Arthritis Management: Can We Treat to Target?

Authors:  Laura J Tucker; Weiyu Ye; Laura C Coates
Journal:  Curr Rheumatol Rep       Date:  2018-09-18       Impact factor: 4.592

Review 8.  Imaging in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and osteoarthritis: An international viewpoint on the current knowledge and future research priorities.

Authors:  Xenofon Baraliakos; Philip G Conaghan; Maria-Antonietta D'Agostino; Walter Maksymowych; Esperanza Naredo; Mikkel Ostergaard; Georg Schett; Paul Emery
Journal:  Eur J Rheumatol       Date:  2019-01

9.  EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.

Authors:  Laure Gossec; Xenofon Baraliakos; Andreas Kerschbaumer; Maarten de Wit; Iain McInnes; Maxime Dougados; Jette Primdahl; Dennis G McGonagle; Daniel Aletaha; Andra Balanescu; Peter V Balint; Heidi Bertheussen; Wolf-Henning Boehncke; Gerd R Burmester; Juan D Canete; Nemanja S Damjanov; Tue Wenzel Kragstrup; Tore K Kvien; Robert B M Landewé; Rik Jozef Urbain Lories; Helena Marzo-Ortega; Denis Poddubnyy; Santiago Andres Rodrigues Manica; Georg Schett; Douglas J Veale; Filip E Van den Bosch; Désirée van der Heijde; Josef S Smolen
Journal:  Ann Rheum Dis       Date:  2020-06       Impact factor: 27.973

10.  Linking the effect of psoriatic arthritis-related foot involvement to the Leeds Foot Impact Scale using the International Classification for Functioning, Disability and Health: a study to assess content validity.

Authors:  Kate Carter; Caterina Tannous; Steven Walmsley; Keith Rome; Deborah E Turner
Journal:  J Foot Ankle Res       Date:  2020-08-24       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.